Passage Bio, Inc. (PASG) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts PASG Hot Sheet
Join SI Premium – FREE
Passage Bio, Inc. (NASDAQ: PASG) reported Q4 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
- Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue
- JPMorgan beats estimates on strong banking fees
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
